Physician

Thomas Stephen Breza, MD

According to 2025 Medicare claims, Thomas Breza, MD (NPI: 1134298011) practices dermatology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is THOMAS STEPHEN BREZA JR MD PA (NPI: 1659600120; TIN: 271353776) and primary practice location at 33308-5017.

Breza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,097 traditional Medicare patients, billed 10,309 HCPCS/CPT codes, and received $799,407 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 348 prescription claims across 165 beneficiaries totaling $40,596 in drug costs, led by Betamethasone Dipropionate (Betamethasone Dipropionate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $413,762 to $799,407. In contrast, Part D prescription costs have declined steadily, from $86,881 to $40,596. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$400K$799K2015 Medicare payment: $413,762 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $524,212 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $464,178 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $495,930 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $622,703 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $610,544 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $704,726 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $697,421 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $788,849 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $799,407 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157154,571$413,762
20167864,918$524,212
20177704,820$464,178
20189165,817$495,930
20191,0777,161$622,703
20201,0226,355$610,544
20211,0406,839$704,726
20221,1117,368$697,421
20231,0828,227$788,849
20241,09710,309$799,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$102K2015 Drug cost: $86,881 (USD; Tot_Drug_Cst)2016 Drug cost: $85,143 (USD; Tot_Drug_Cst)2017 Drug cost: $85,538 (USD; Tot_Drug_Cst)2018 Drug cost: $101,556 (USD; Tot_Drug_Cst)2019 Drug cost: $58,093 (USD; Tot_Drug_Cst)2020 Drug cost: $18,623 (USD; Tot_Drug_Cst)2021 Drug cost: $16,994 (USD; Tot_Drug_Cst)2022 Drug cost: $57,037 (USD; Tot_Drug_Cst)2023 Drug cost: $25,886 (USD; Tot_Drug_Cst)2024 Drug cost: $40,596 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015255641$86,881
2016275612$85,143
2017250539$85,538
2018253533$101,556
2019243522$58,093
2020221508$18,623
2021246501$16,994
2022240467$57,037
2023175335$25,886
2024165348$40,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks329425$497
11102Biopsy of related skin growth, first growth482663$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8081,530$62
17000Destruction of precancer skin growth, 1 growth525851$35
17003Destruction of precancer skin growth, 2-14 growths4182,406$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Betamethasone DipropionateBetamethasone Dipropionate491,555$1,622
FluorouracilFluorouracil12360$827
MetronidazoleMetronidazole11280$673
KetoconazoleKetoconazole291,005$428
ValacyclovirValacyclovir Hcl15252$401

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Thomas Stephen Breza, MD?

Tedicare shows public-source Medicare data for Thomas Stephen Breza, MD (NPI 1134298011), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Stephen Breza, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Stephen Breza, MD?

Thomas Stephen Breza, MD is linked to THOMAS STEPHEN BREZA JR MD PA (billing NPI 1659600120) in the available physician profile data.

Does Thomas Stephen Breza, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.